Last $0.42 USD
Change Today -0.01 / -2.33%
Volume 63.3K
MBLX On Other Exchanges
Symbol
Exchange
MBLX is not on other exchanges.
As of 8:10 PM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

metabolix inc (MBLX) Snapshot

Open
$0.41
Previous Close
$0.43
Day High
$0.46
Day Low
$0.40
52 Week High
03/18/14 - $1.67
52 Week Low
12/10/14 - $0.25
Market Cap
56.8M
Average Volume 10 Days
106.1K
EPS TTM
$-0.81
Shares Outstanding
135.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for METABOLIX INC (MBLX)

Related News

No related news articles were found.

metabolix inc (MBLX) Related Businessweek News

No Related Businessweek News Found

metabolix inc (MBLX) Details

Metabolix, Inc., a bioscience company, focuses on delivering sustainable solutions to the plastics and chemicals industries. It produces a family of biopolymers found in nature called polyhydroxyalkanoates, which occur naturally in living organisms and are chemically similar to polyesters. The company offers its biopolymers under the Mirel and Mvera brand names. It is also developing biobased industrial C4 and C3 chemicals; and harnessing the renewable nature of plants to make renewable chemicals and bioenergy from crops. Metabolix, Inc. was founded in 1992 and is based in Cambridge, Massachusetts.

98 Employees
Last Reported Date: 03/28/14
Founded in 1992

metabolix inc (MBLX) Top Compensated Officers

Co-Founder, Chief Scientific Officer and Dire...
Total Annual Compensation: $240.0K
Chief Operating Officer
Total Annual Compensation: $278.3K
Vice President of Marketing and Corporate Com...
Total Annual Compensation: $220.0K
Compensation as of Fiscal Year 2013.

metabolix inc (MBLX) Key Developments

Metabolix, Inc. Presents at 17th Annual Needham Growth Conference, Jan-13-2015 03:10 PM

Metabolix, Inc. Presents at 17th Annual Needham Growth Conference, Jan-13-2015 03:10 PM. Venue: New York Palace Hotel, 455 Madison Avenue, New York, New York, United States.

Metabolix, Inc. Receives Approval From Nasdaq To Transfer Listing Of Common Stock From Nasdaq Global Market To Nasdaq Capital Market

On January 5, 2015, Metabolix, Inc. received approval from the Nasdaq Stock Market (Nasdaq) to transfer the listing of the company’s common stock from the Nasdaq Global Market to the Nasdaq Capital Market. This transfer will be effective at the opening of business on January 7, 2015. As previously reported, the company was notified by Nasdaq on July 7, 2014, that it no longer satisfied the minimum bid price requirement for continued listing of $1.00 per share, as set forth in Nasdaq Listing Rule 5450(a)(1). In anticipation of not meeting the minimum bid price requirement by January 5, 2015, the end of its initial 180-day grace period, the company applied to transfer the listing of its stock to The Nasdaq Capital Market. Upon transfer to the Capital Market, the company is being afforded an additional 180-day grace period to regain compliance with the Nasdaq’s minimum bid price requirement. In order to regain compliance, the minimum bid price per share of the company’s common stock must be at least $1.00 for at least ten consecutive business days during the second 180-day grace period, which will end on July 6, 2015. If the company fails to regain compliance during this grace period, the company’s common stock will be subject to delisting by Nasdaq. The company has provided written notice of its intention to cure the minimum bid price deficiency during the second grace period by effecting a reverse stock split if necessary.

Metabolix Provides Update on Biopolymer Manufacturing Plans

Metabolix, Inc. provided an update on the company's biopolymer manufacturing plans. Metabolix plans to significantly increase output of Mirel® PHA biopolymers at its contracted pilot manufacturing facilities. The initial focus of this manufacturing plan will be production of the Company's a-PHA (amorphous, low Tg rubber) biopolymer for use in ongoing development activities based on this unique PHA product. This new PHA material, together with existing inventory, is intended to support both market development and initial customer conversions as Metabolix continues working to build its biopolymers business based on PHA performance additives.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MBLX:US $0.42 USD -0.01

MBLX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MBLX.
View Industry Companies
 

Industry Analysis

MBLX

Industry Average

Valuation MBLX Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact METABOLIX INC, please visit www.metabolix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.